Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial.
| Autor: | Creamer AW; Respiratory Medicine, North Bristol NHS Trust, Westbury on Trym, UK., Barratt SL; Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Westbury on Trym, UK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Breathe (Sheffield, England) [Breathe (Sheff)] 2019 Jun; Vol. 15 (2), pp. 140-143. |
| DOI: | 10.1183/20734735.0002-2019 |
| Abstrakt: | The AmbOx trial provides RCT evidence for ambulatory oxygen therapy improving HRQoL in patients with fibrotic ILD http://ow.ly/uHC030nEzsz. Competing Interests: Conflict of interest: A.W. Creamer has nothing to disclose. Conflict of interest: S.L. Barratt has nothing to disclose. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|